<DOC>
	<DOC>NCT00289107</DOC>
	<brief_summary>The study will evaluate the clinical performance of the rotating platform and fixed bearing implants through patient questionnaires, outcomes scoring and radiographic assessment.</brief_summary>
	<brief_title>Randomized Fixed Bearing vs Mobile Bearing Cruciate Substituting TKA</brief_title>
	<detailed_description>The study will evaluate the clinical performance of rotating platform and fixed bearing cruciate ligament substituting implants by obtaining a series of primary TKAS. Patients will receive either the P.F.C.® Sigma™ Rotating Platform Cruciate Substituting Knee System or P.F.C.® Sigma™ Fixed Cruciate Substituting Knee System and assignment is randomized.</detailed_description>
	<mesh_term>Arthritis</mesh_term>
	<mesh_term>Osteoarthritis</mesh_term>
	<mesh_term>Arthritis, Rheumatoid</mesh_term>
	<mesh_term>Necrosis</mesh_term>
	<mesh_term>Arthritis, Juvenile</mesh_term>
	<criteria>Osteoarthritis Rheumatoid arthritis Other inflammatory arthritis Avascular necrosis (AVN) of bone PostTraumatic Arthritis Juvenile Rheumatoid Arthritis History of recent/active joint sepsis. Charcot neuropathy. Psychosocial disorders that would limit rehabilitation. Greater than 75 years of age at the time of surgery. Prior ipsilateral knee arthroplasty. Metabolic disorders of calcified tissues, such as Paget's disease. Severe diabetes mellitus. Joint replacement due to autoimmune disorders. Skeletal immaturity</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>August 2013</verification_date>
	<keyword>Total Knee Replacement</keyword>
	<keyword>Knee Prosthesis</keyword>
</DOC>